Defence Therapeutics Inc.
DTC
Clasificación en acciones
#29522
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Precio por acción
$0.25964327
Última sincronización: 2026-10-21
Capitalización bursátil
$19.68M
Cambio (1 día)
0.00%
Cambio (1 año)
-55.64%
País
CA
Comercio Defence Therapeutics Inc. (DTC)
Categoría
Healthcare
Historial del precio de la acción de Defence Therapeutics Inc. (DTC)
Precio más alto de cierre: $0.27 el 2026-10-01
Precio más bajo de cierre: $2.50 el 2021-05-01
Precio más bajo de cierre: $2.50 el 2021-05-01
Historial del precio de la acción de Defence Therapeutics Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.44 | -4.05% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
